rs1555091084
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP6_Very_Strong
The NM_000051.4(ATM):c.3403-15_3403-14insTA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000535 in 1,556,992 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000051.4 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATM | NM_000051.4 | c.3403-15_3403-14insTA | intron_variant | Intron 23 of 62 | ENST00000675843.1 | NP_000042.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000211 AC: 32AN: 151728Hom.: 0 Cov.: 0
GnomAD3 exomes AF: 0.000556 AC: 129AN: 231976Hom.: 0 AF XY: 0.000548 AC XY: 69AN XY: 125826
GnomAD4 exome AF: 0.000570 AC: 801AN: 1405146Hom.: 1 Cov.: 31 AF XY: 0.000564 AC XY: 395AN XY: 700236
GnomAD4 genome AF: 0.000211 AC: 32AN: 151846Hom.: 0 Cov.: 0 AF XY: 0.000242 AC XY: 18AN XY: 74258
ClinVar
Submissions by phenotype
not specified Benign:1
- -
Breast and/or ovarian cancer Benign:1
- -
ATM-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Familial ovarian cancer Benign:1
The ATM c.3403-15_3403-14insTA variant was identified in the following databases: dbSNP (ID: rs3218681) “With Benign, other allele”, and in control databases in 144695 (40554 homozygous) of 258930 chromosomes at a frequency of 0.6 (Genome Aggregation Consortium Feb 27, 2017), falling on 3 transcripts with a population breakdown of: South Asian in 16377 (5070 homozygous) of 26642 chromosomes (freq: 0.6), European (Finnish) in 14916 (4483 homozygous) of 24280 chromosomes (freq: 0.6), Latino in 19186 (5780 homozygous) of 31316 chromosomes (freq: 0.6), Ashkenazi Jewish in 5646 (1697 homozygous) of 9232 chromosomes (freq: 0.6), Other in 3528 (1050 homozygous) of 5964 chromosomes (freq: 0.6), European (Non-Finnish) in 67483 (18810 homozygous) of 119980 chromosomes (freq: 0.6), African in 10689 (2402 homozygous) of 23444 chromosomes (freq: 0.5), and East Asian in 6870 (1262 homozygous) of 18072 chromosomes (freq: 0.4). The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign. -
Hereditary cancer-predisposing syndrome Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at